1989
DOI: 10.1007/bf01963770
|View full text |Cite
|
Sign up to set email alerts
|

Chronic systemic candidiasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
40
0

Year Published

1990
1990
2015
2015

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(40 citation statements)
references
References 18 publications
0
40
0
Order By: Relevance
“…First, risk factors for invasive fungal infections are not the same in all neutropenic patients (12). Second, chronic systemic candidiasis initiated by neutropenia may persist despite normal PMN counts and adequate antifungal therapy (13). Third, some patients, particularly transplant recipients who have adequate or even normal PMN counts, may be at high risk for invasive mycoses (14).…”
mentioning
confidence: 99%
“…First, risk factors for invasive fungal infections are not the same in all neutropenic patients (12). Second, chronic systemic candidiasis initiated by neutropenia may persist despite normal PMN counts and adequate antifungal therapy (13). Third, some patients, particularly transplant recipients who have adequate or even normal PMN counts, may be at high risk for invasive mycoses (14).…”
mentioning
confidence: 99%
“…However, changes in the host environment may lead to opportunistic infections caused by Candida particularly oral, genital and gastrointestinal infections (Bodey, 1993). Infection caused by C. albicans and C. tropicalis can be broadly divided into two categories: Superficial mucocutaneous infections (Ashman and Papadimitriou, 1990) and systematic infections involving the spread of C. albicans to the blood stream (candidemia) and to other major organs (Bodey and Anaissie, 1989). Superficial infections affect various mucous membranes such as in oral and vaginal thrush.…”
Section: Introductionmentioning
confidence: 99%
“…It is believed that the illness is due to minor changes in epithelial environment such as pH, altered glucose/glycogen concentration or changes in epithelial integrity. Candida tropicalis is considered to be one of the leading Candida species, next only to C. albicans, to cause fungemia in patients with cancer (Bodey and Anaissie, 1989;Wingard, 1995). During the 1970s and 1980s, several studies reported that C. tropicalis fungemia, was common in patients with leukemia and in those who had received bone marrow transplants (Abi-Said et al, 1997;Ashman and Papadimitriou, 1990).…”
Section: Introductionmentioning
confidence: 99%
“…The yeast Candida albicans is a major opportunistic pathogen, the prevalance of which is increasing in virtually all groups of immunosuppressed or immunocompromised patients (1). Although clinical observations have consistently indicated that candidiasis occurs in association with defective cell-mediated immune responses, the relationship has been difficult to analyse either in human subjects or in experimental animals, and consequently is still rather contentious.…”
Section: Introducnonmentioning
confidence: 99%